{
    "code": "52027923",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52027923",
    "time": "2021-10-22 03:32:32",
    "許可證字號": "衛部藥輸字第027923號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/07\/31",
    "發證日期": "109\/07\/31",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202792303",
    "中文品名": "維萬心軟膠囊61毫克",
    "英文品名": "Vyndamax soft Capsules 61 mg",
    "適應症": "用於治療成人野生型或遺傳性的轉甲狀腺素蛋白類澱粉沉著症造成之心肌病變(transthyretin-mediated amyloid cardiomyopathy)，以降低總死亡率和心血管疾病住院。",
    "劑型": "132軟膠囊劑",
    "包裝": "2-1000粒PVC\/Aluminum Foil\/oPA\/PVC鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "新成分",
    "監視期限": "114\/07\/31",
    "主成分略述": "tafamidis",
    "限制項目": "02輸　入 5F免除銜接性試驗",
    "申請商名稱": "0929101100  美商惠氏藥廠（亞洲）股份有限公司台灣分公司",
    "申請商地址": "台北市信義區松仁路100號42、43樓",
    "主製造廠": [
        {
            "": "UNITED STATES",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6605071926  久裕企業股份有限公司",
            "製造廠廠址": "桃園市桃園區大林里興邦路43巷2之1號4樓，3樓B區，1樓A區",
            "製造廠公司地址": "",
            "製造廠國別": "",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "FGB0219100  ANDERSONBRECON (UK) LTD",
            "製造廠廠址": "UNITS 2-7, WYE VALLEY BUSINESS PARK, BRECON ROAD, HAY-ON-WYE, HEREFORD, HEREFORDSHIRE, HR3 5PG, UNITED KINGDOM",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED KINGDOM",
            "製程": "二級包裝廠"
        },
        {
            "製造廠名稱": "FUS2401000  AndersonBrecon Inc",
            "製造廠廠址": "4545 ASSEMBLY DRIVE, ROCKFORD, IL 61109 USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "包裝"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200050000",
            "成分名稱": "tafamidis",
            "含量描述": "",
            "含量": "61.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "202009_Vyndamax_61mg_appearance-109-09-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027923&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Vyndamax仿單-SPC 20190107-5-110-10-14(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027923&Seq=003&Type=9"
        },
        {
            "title": "Vyndamax_仿單_SPC 20190107-4-110-01-18(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027923&Seq=002&Type=9"
        },
        {
            "title": "109.8.6 Vyndamax仿單最新版-109-08-12.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027923&Seq=001&Type=9"
        },
        {
            "title": "Vyndamax_外盒-110-10-14(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027923&Seq=010&Type=8"
        },
        {
            "title": "區段 002 - 426411_4._外盒黏貼表_Vyndamax_CTN_Foil_LAB-110-07-22-110-09-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027923&Seq=009&Type=8"
        },
        {
            "title": "139519_04 Vyndamax_printed sticker_US-110-09-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027923&Seq=008&Type=8"
        },
        {
            "title": "139520_05 Proposed AW_US_carton_foil-110-09-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027923&Seq=007&Type=8"
        },
        {
            "title": "202109_Vyndamax_61mg_CTN and Foil_au-110-09-06(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52027923&Seq=006&Type=8"
        }
    ]
}